| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |